AzTrials
AzTrials

Insulin SensitivityNCT03941704

Pulse-based Foods for Alleviation of Negative Consequences of Sedentary Behaviour

A study testing Pulse-based diet and Regular diet in people with Insulin Sensitivity, run by University of Saskatchewan at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The hypothesis is that consumption of pulse-based foods (i.e. containing chickpeas, lentils, and split peas) during the workday will improve insulin sensitivity, glucose tolerance, blood lipids, body composition, and blood pressure in sedentary office workers.One-hundred office workers from a university campus will… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Insulin Sensitivity
What is being tested?
Pulse-based diet and Regular diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteCanada
Study dates
15 May 2019to 30 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Men and Women
  • 18y or older
  • Engaged in >5 hours per day sitting

Who cannot join

  • Diagnosed with diabetes
  • taking glucose or lipid-lowering medication
  • Regular consumers of pulses (1.5 cups (250g) or greater of pulses per week)
  • Engaged in 60 minutes or greater of physical activity per day

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • College of Kinesiology, University of Saskatchewan

    Saskatoon, Saskatchewan, S7N5B2

Other trials in Canada

About this study

Official title: Development of Pre-Packaged Pulse-Based Meals to Ameliorate the Negative Health Consequences of Sedentary Behavior

The hypothesis is that consumption of pulse-based foods (i.e. containing chickpeas, lentils, and split peas) during the workday will improve insulin sensitivity, glucose tolerance, blood lipids, body composition, and blood pressure in sedentary office workers.One-hundred office workers from a university campus will participate in a cross-over study where they will be randomized (i.e. assigned by chance) to receive pre-packaged pulse-based lunches and snacks to replace their usual lunches/snacks during the work day OR to continue consuming their usual diets for two months. After the first dietary intervention, they will undergo a 1-month "wash-out" and then participate in two months of the opposite dietary intervention. The main outcome to be assessed is change in glucose and insulin (i.e. blood sugar control) determined during an oral glucose tolerance test. Secondary outcomes include changes in body composition, lipids, and blood pressure.

During the pulse-based diet phases, participants will be supplied with a ready-to-eat lunch and two snacks to eat during each workday. These will contain a total of 150g/d dry weight (250g/d wet weight) pulses

Read the detailed description

Sedentary behaviour has been deemed the "new smoking" based on multiple and potent negative impacts on health. Moreover, sedentary behaviour is a strong predictor of type 2 diabetes risk and cardiovascular disease. Previous studies have show that pulse-based meals derived from lentils, beans, chickpeas, and peas are effective for alleviating risk factors associated with diabetes and cardiovascular disease in clinical populations including older adults, overweight and obese individuals, and women with polycystic ovary syndrome; however, to date, there have been no nutrition-based interventions for alleviating risk factors for diabetes specifically targeting office workers exposed to long periods of sitting. Although people are aware of the health benefits of pulses, a major barrier to increased consumption continues to be a lack of knowledge on how to prepare pulse-based meals. This proposed study is designed to overcome this barrier. The main goal of this research study is to determine whether improvements in cardio-metabolic health can be realized by giving people pulse-based lunches and snacks to replace their regular workplace lunches and snacks. In this randomized controlled trial, 100 office workers from the University of Saskatchewan will participate in a cross-over study where they will be randomized into one of two diets for 2 months: Receive pre-packaged pulse-based lunches and snacks to replace their usual lunches/snacks during the work day OR to continue consuming their usual diets for two months. After a one-month washout, they will cross-over to the other condition. The primary outcome measure, Matsuda Index (determined by blood glucose and insulin responses to an oral glucose tolerance test), will be assessed before each diet phase and at the end (i.e. two months) of each diet phase. Secondary outcome measures (body composition, waist girth, lipids, blood pressure will also be assessed.

Being tested
Pulse-based diet, Regular diet
Medical subject headings
Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulse-based dietDietary supplement

    Low Glycemic Index

  • Regular dietDietary supplement

    Moderate Glycemic Index

Study groups in NCT03941704
Study groupRoleWhat they receive
Low Glycemic IndexExperimentalPulse-based diet
Receives: Dietary Supplement: Pulse-based diet
Moderate Glycemic IndexActive comparatorRegular diet
Receives: Dietary Supplement: Regular diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insulin sensitivity

    Matsuda Index determined by glucose and insulin response to oral glucose tolerance test

    Measured: Change from baseline to 8 weeks

Secondary outcomes (13)
  1. Glucose area under the curve

    Glucose area under the curve from a 2-hour oral glucose tolerance test

    Measured: Change from baseline to 8 weeks

  2. Insulin area under the curve

    Insulin area under the curve from a 2-hour oral glucose tolerance test

    Measured: Change from baseline to 8 weeks

  3. Fasting glucose

    Fasting glucose

    Measured: Change from baseline to 8 weeks

  4. Fasting insulin

    Fasting insulin

    Measured: Change from baseline to 8 weeks

  5. Low-density lipoprotein cholesterol

    LDL-C from fasting blood samples

    Measured: Change from baseline to 8 weeks

  6. High-density lipoprotein cholesterol

    HDL-C from fasting blood samples

    Measured: Change from baseline to 8 weeks

  7. Total cholesterol

    Total cholesterol from fasting blood samples

    Measured: Change from baseline to 8 weeks.

  8. Triglycerides

    Triglycerides from fasting blood samples

    Measured: Change from baseline to 8 weeks

  9. Waist Girth

    Waist Girth

    Measured: Change from baseline to 8 weeks

  10. Fat mass

    Fat mass from DXA measurements

    Measured: Change from baseline to 8 weeks

  11. Lean tissue mass

    Lean tissue mass from DXA measurements

    Measured: Change from baseline to 8 weeks

  12. Systolic blood pressure

    Systolic blood pressure measured at rest

    Measured: Change from baseline to 8 weeks

  13. Diastolic blood pressure

    Diastolic blood pressure measured at rest

    Measured: Change from baseline to 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2019
  2. Study start15 May 2019
  3. Primary completion15 May 2021
  4. Study completion30 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Model description
Crossover: 1. Pulse-based diet; 2. Regular diet
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03941704
Sponsor's protocol ID
609
Status last verified
Oct 2021
First submitted
6 May 2019
Last updated
21 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bertrand L, Shaw KA, Hood-Niefer S, Ko J, Gordon J, Zello GA, Chilibeck PD. Consumer Acceptability and Metabolic Health Benefits of Meals Containing Pulses (Chickpeas, Lentils, Peas) for Sedentary Office Workers. Foods. 2026 Sep 18;15(18):3302. doi: 10.3390/foods15183302.

    PubMed 42794087

Questions about this trial

What is this clinical trial studying?

A study testing Pulse-based diet and Regular diet in people with Insulin Sensitivity, run by University of Saskatchewan at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insulin sensitivity (time frame: Change from baseline to 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03941704, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in